Evidence map›Paper›PMID 29351058›Full record

ArticleRadiation research2018

Development and Characterization of an In Vitro Model for Radiation-Induced Fibrosis.

Dhruv Kumar, Sreeya Yalamanchali, Jacob New, Sean Parsel, Natalie New, Andrew Holcomb, Sumedha Gunewardena, Ossama Tawfik, Chris Lominska, Bruce F Kimler and 7 more

Open access · greenAbstract read
In one paragraph

Article in Radiation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Dhruv KumarDepartment of a   Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Sreeya YalamanchaliDepartment of a   Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Jacob NewDepartment of a   Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Sean ParselDepartment of a   Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Natalie NewDepartment of a   Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Andrew HolcombDepartment of a   Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Sumedha Gunewardenac   Department of Molecular and Integrative Physiology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Ossama Tawfikd   Department of Pathology and Laboratory Medicine, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Chris Lominskae   Department of Radiation Oncology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Bruce F Kimlere   Department of Radiation Oncology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Shrikant Anantf   Department of Surgery, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Kiran KakaralaDepartment of a   Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Terance TsueDepartment of a   Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Yelizaveta ShnayderDepartment of a   Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Kevin SykesDepartment of a   Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
Subhash Padhyeh   Interdisciplinary Science and Technology Research Academy, University of Pune, Pune, India.
Sufi Mary ThomasDepartment of a   Otolaryngology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, Kansas.
The University of Kansas Cancer Center · USUniversity of Kansas Medical Center · USSavitribai Phule Pune University · IN

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
Transgenic and Gener-Targeting CoreP20GM104936 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SAADI, IRFAN · 2012 to 2016
$10.9M
Using PCORnet to Expand the DS-CONNECT Cohort Through Healthcare System Recruitment, Incorporating Electronic Health Records, and Assessing Self-DeterminationU54HD090216 · NICHD · UNIVERSITY OF KANSAS LAWRENCE · PI COLOMBO, JOHN A. · 2016 to 2020
$6.2M
Molecular Regulation of Cell Development and Differentiation Phase III COBREP30GM122731 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LITTLE, CHARLES D. · 2017 to 2021
$5.6M
Novel Approaches for the Control of Microbial PathogensP30GM103326 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LUTKENHAUS, JOSEPH F · 2012 to 2016
$5.3M
NCI NIH HHS P30 CA168524NICHD NIH HHS U54 HD090216NIGMS NIH HHS P20 GM104936NIGMS NIH HHS P30 GM103326NIGMS NIH HHS P30 GM122731
6 · The paper itself

Abstract

Radiation-induced fibrosis (RIF) is a major side effect of radiotherapy in cancer patients with no effective therapeutic options. RIF involves excess deposition and aberrant remodeling of the extracellular matrix (ECM) leading to stiffness in tissues and organ failure. Development of preclinical models of RIF is crucial to elucidate the molecular mechanisms regulating fibrosis and to develop therapeutic approaches. In addition to radiation, the main molecular perpetrators of fibrotic reactions are cytokines, including transforming growth factor-β (TGF-β). We hypothesized that human oral fibroblasts would develop an in vitro fibrotic reaction in response to radiation and TGF-β. We demonstrate here that fibroblasts exposed to radiation followed by TGF-β exhibit a fibrotic phenotype with increased collagen deposition, cell proliferation, migration and invasion. In this in vitro model of RIF (RIF

Indexed as

Cell MovementCell ProliferationCollagenCurcuminExtracellular MatrixFibroblastsFibrosisGene Expression RegulationHepatocyte Growth FactorHumansIntegrinsPentoxifyllineRadiation InjuriesTransforming Growth Factor betaCollagenCurcuminHepatocyte Growth FactorIntegrinsPentoxifyllineTransforming Growth Factor beta

Identifiers

PMID29351058
PMCPMC5837959
OpenAlexW2788634622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.